New analysis method maps risks tied to CRISPR edits
A new screening workflow compares intended edits with off-target changes, giving research teams a faster way to review candidate designs.
Platform and other
United States
Research results, partnerships, regulatory steps, and clinical updates, in one feed.
A new screening workflow compares intended edits with off-target changes, giving research teams a faster way to review candidate designs.
The submission could clarify how gene-edited produce is assessed separately from conventional GMO pathways in the region.
An early-stage program is enrolling an additional patient group as investigators evaluate durability and safety signals.
Each item is labeled with one of these fields.
Sign in with your GenomeSync account to see the full list.